pharma news from FierceHealthcare
NewsMedical societies financially tied to drugmakers
Concerns over conflicts of interest between pharmacy and medicine have caused several medical schools to kick drugmakers and marketers off their grounds. However, it seems medical societies still Read more...
SPOTLIGHT: AMA conflict of interest policy still in the works, a year later
Some might say a year of debate is long enough, even for Congress. But at the American Medical Association, they're taking their time over a new ethics policy designed to limit pharmaceutical company Read more...
IOM offers pharma-physician conflict-of-interest guidelines
Regulations, laws and policies limiting the way physicians interact with pharmaceutical and medical device companies have been flying thick and fast over the past couple of years. It's no surprise, Read more...
VT may toughen pharma regulations; Study says tight privacy laws slow EMR adoption;
> Vermont already requires drugmakers to list payments made to physicians, by dollar amounts. Now, lawmakers are looking to close a loophole that allows pharmas to keep some payments private by Read more...
AstraZeneca asks judge to nullify $215M drug-price lawsuit
Drugmaker AstraZeneca has asked an Alabama judge to nullify a jury verdict that ordered it to pay the state $215 million in damages in a Medicaid drug-price fraud suit. The state's 2005 suit accused Read more...
Pharma gift disclosure law wins Eli Lilly support
While its peers appear to be firmly opposed to such rules, pharmaceutical giant Eli Lilly has decided to support federal legislation that would require drugmakers to disclose payments to doctors. Read more...
ALSO NOTED: Plavix copycat on the rise in Europe; Hospital bills for services to dead patient; and much more...
> Pharma giants Sanofi-Aventis and Bristol-Myers Squibb are preparing to battle a copycat generic to its Plavix brand. Read more...
Trend: Medical schools discourage use of demeaning slang
Getting through medical school is a tough indoctrination into a close-knit fraternity, so it's no surprise that people develop their own culture. One aspect of that culture is the adoption of Read more...
College group urges ban on drug, devicemaker freebies
The association representing U.S. medical colleges has come out with a proposed ban on pharma and device-maker gifts on medical college campuses. The group, the Association of American Medical Read more...
Louisiana MDs win legal battle over patient record disclosure
A group of Louisiana physicians have won their battle to keep their patients' records out of the hands of a pharmaceutical company--though they may face future challenges on the issue. The dispute Read more...
| Press Releases2011 Achievements and 2012 Prospects BioAlliance Pharma Confirms the Dynamics of Its Core BusinessPARIS--(BUSINESS WIRE)-- Regulatory News: BioAlliance Pharma SA (Paris:BIO) (Euronext Paris - BIO), a company dedicated to specialty and orphan oncology products, today announces its 2011 Read more >> Lexington, KY Market Provides Opportunities for Pharma SalesGovernor’s Veto of Proposed Health System Merger Means Business as Usual For Pharma, According to a Recent Market Overview Now Available from HealthLeaders-InterStudy NASHVILLE, Tenn.--(BUSINESS Read more >> Strategic changes by big pharma accounted for 60% of partnership deal terminations between January 2010 and June 2011: com40% of pharmaceutical partnership deals terminated between January 2010 and June 2011 were valued at $400m-$600mStrategic changes are cited as the most common reason behind pharmaceutical deal Read more >> Drug Dropout in Clinical Trials Is at Unsustainable Levels, According to Thomson Reuters, CMR InternationalPHILADELPHIA and LONDON, June 26, 2011 /PRNewswire/ -- The pharmaceutical industry spent less on drug R&D last year than at any time in the last three years, according to data released today from Read more >> AMATSI (Formerly CRID Pharma) and AVOGADRO Combine Strengths to Become the French Leader in Drug Development ServicesMONTPELLIER, France--(BUSINESS WIRE)-- AMATSI (formerly known as CRID Pharma) and AVOGADRO, two contract drug development organizations, have today announced that they will combine to become the Read more >> |
